Treatment targets for right ventricular dysfunction in pulmonary arterial hypertension
Right ventricle (RV) dysfunction is the strongest predictor of mortality in pulmonary arterial
hypertension (PAH), but, at present, there are no therapies directly targeting the failing RV …
hypertension (PAH), but, at present, there are no therapies directly targeting the failing RV …
Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
SZ Prisco, T Thenappan, KW Prins - JACC. Basic to Translational …, 2020 - europepmc.org
Right ventricle (RV) dysfunction is the strongest predictor of mortality in pulmonary arterial
hypertension (PAH), but, at present, there are no therapies directly targeting the failing RV …
hypertension (PAH), but, at present, there are no therapies directly targeting the failing RV …
[HTML][HTML] Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
SZ Prisco, T Thenappan, KW Prins - JACC: Basic to Translational …, 2020 - ncbi.nlm.nih.gov
Right ventricle (RV) dysfunction is the strongest predictor of mortality in pulmonary arterial
hypertension (PAH), but, at present, there are no therapies directly targeting the failing RV …
hypertension (PAH), but, at present, there are no therapies directly targeting the failing RV …
Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
SZ Prisco, T Thenappan, KW Prins - JACC: Basic to Translational …, 2020 - experts.umn.edu
Right ventricle (RV) dysfunction is the strongest predictor of mortality in pulmonary arterial
hypertension (PAH), but, at present, there are no therapies directly targeting the failing RV …
hypertension (PAH), but, at present, there are no therapies directly targeting the failing RV …
[引用][C] Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
SZ Prisco, T Thenappan, KW Prins - JACC: Basic to Translational …, 2020 - cir.nii.ac.jp
Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォーム …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォーム …
Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
SZ Prisco, T Thenappan… - JACC. Basic to …, 2020 - pubmed.ncbi.nlm.nih.gov
Right ventricle (RV) dysfunction is the strongest predictor of mortality in pulmonary arterial
hypertension (PAH), but, at present, there are no therapies directly targeting the failing RV …
hypertension (PAH), but, at present, there are no therapies directly targeting the failing RV …
[HTML][HTML] Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
SZ Prisco, T Thenappan, KW Prins - JACC: Basic to Translational Science, 2020 - Elsevier
Right ventricle (RV) dysfunction is the strongest predictor of mortality in pulmonary arterial
hypertension (PAH), but, at present, there are no therapies directly targeting the failing RV …
hypertension (PAH), but, at present, there are no therapies directly targeting the failing RV …
Treatment Targets for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension.
SZ Prisco, T Thenappan, KW Prins - JACC. Basic to Translational …, 2020 - europepmc.org
Right ventricle (RV) dysfunction is the strongest predictor of mortality in pulmonary arterial
hypertension (PAH), but, at present, there are no therapies directly targeting the failing RV …
hypertension (PAH), but, at present, there are no therapies directly targeting the failing RV …